Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.
Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ. Hope WW, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2010 Nov;54(11):4879-86. doi: 10.1128/AAC.00673-10. Epub 2010 Aug 16. Antimicrob Agents Chemother. 2010. PMID: 20713673 Free PMC article.
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
Petraitiene R, Petraitis V, Groll AH, Sein T, Schaufele RL, Francesconi A, Bacher J, Avila NA, Walsh TJ. Petraitiene R, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2002 Jan;46(1):12-23. doi: 10.1128/AAC.46.1.12-23.2002. Antimicrob Agents Chemother. 2002. PMID: 11751105 Free PMC article.
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ. Petraitis V, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2002 Jun;46(6):1857-69. doi: 10.1128/AAC.46.6.1857-1869.2002. Antimicrob Agents Chemother. 2002. PMID: 12019101 Free PMC article.
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ. Petraitiene R, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2004 Apr;48(4):1188-96. doi: 10.1128/AAC.48.4.1188-1196.2004. Antimicrob Agents Chemother. 2004. PMID: 15047519 Free PMC article.
Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis.
Petraitis V, Petraitiene R, Lin P, Calis K, Kelaher AM, Muray HA, Mya-San C, Mickiene D, Bacher J, Walsh TJ. Petraitis V, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2005 Apr;49(4):1642-5. doi: 10.1128/AAC.49.4.1642-1645.2005. Antimicrob Agents Chemother. 2005. PMID: 15793161 Free PMC article.
Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.
Petraitis V, Petraitiene R, Solomon J, Kelaher AM, Murray HA, Mya-San C, Bhandary AK, Sein T, Avila NA, Basevicius A, Bacher J, Walsh TJ. Petraitis V, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2006 Apr;50(4):1510-7. doi: 10.1128/AAC.50.4.1510-1517.2006. Antimicrob Agents Chemother. 2006. PMID: 16569871 Free PMC article.
Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
Petraitiene R, Petraitis V, Hope WW, Mickiene D, Kelaher AM, Murray HA, Mya-San C, Hughes JE, Cotton MP, Bacher J, Walsh TJ. Petraitiene R, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2008 Nov;52(11):4121-9. doi: 10.1128/AAC.00674-08. Epub 2008 Sep 8. Antimicrob Agents Chemother. 2008. PMID: 18779361 Free PMC article.
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. Petraitis V, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23. Antimicrob Agents Chemother. 2009. PMID: 19307368 Free PMC article.
Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
Gastine S, Hope W, Hempel G, Petraitiene R, Petraitis V, Mickiene D, Bacher J, Walsh TJ, Groll AH. Gastine S, et al. Among authors: bacher j. Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01574-20. doi: 10.1128/AAC.01574-20. Print 2021 Jan 20. Antimicrob Agents Chemother. 2021. PMID: 33168606 Free PMC article.
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V, Petraitiene R, Groll AH, Bell A, Callender DP, Sein T, Schaufele RL, McMillian CL, Bacher J, Walsh TJ. Petraitis V, et al. Among authors: bacher j. Antimicrob Agents Chemother. 1998 Nov;42(11):2898-905. doi: 10.1128/AAC.42.11.2898. Antimicrob Agents Chemother. 1998. PMID: 9797223 Free PMC article.
239 results